$1.16
N/A
At close: Sep 4, 5:00 PM EST
$1.10
-0.06-5.17%
After Hours: Sep 4, 4:55 PM EST
Telomir Pharmaceuticals Inc Stock News
TELONASDAQ
Latest Telomir Pharmaceuticals Stock News | NASDAQ:TELO | Benzinga
Get the latest news on Telomir Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Telomir Pharmaceuticals performance
Categories: All
Monday, August 10, 2026
Tuesday, August 04, 2026
Tuesday, July 21, 2026
Friday, July 17, 2026
Monday, June 15, 2026
Monday, June 08, 2026
Wednesday, May 20, 2026
Thursday, April 30, 2026
Tuesday, March 31, 2026
Tuesday, February 17, 2026
Thursday, February 05, 2026
Tuesday, January 06, 2026
Monday, January 05, 2026
Thursday, December 18, 2025
Wednesday, December 17, 2025
Tuesday, November 25, 2025
Friday, November 21, 2025
Thursday, November 20, 2025
Wednesday, November 12, 2025
Monday, November 10, 2025
Thursday, October 23, 2025
Wednesday, October 22, 2025
Tuesday, October 21, 2025
Monday, October 20, 2025
Tuesday, October 14, 2025
Thursday, October 09, 2025
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- Telomir Pharmaceuticals Touts Promising Action From Its Lead Breast Cancer Drug
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Telomir Pharmaceuticals shares are trading hi...PRO
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Telomir Pharmaceuticals Announces Findings in...PRO
- Market-Moving News for October 9thPRO
- Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Wednesday, October 08, 2025
Tuesday, October 07, 2025
- Stock Market Today: Dow Jones, Nasdaq 100, S&P 500 Futures Turn Green—Trilogy Metals, AMD, Applovin In Focus (UPDATED)
- Telomir Reports Preclinical Data Showing Telo...PRO
- Market-Moving News for October 7thPRO
- Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
- McCormick, Telomir Pharmaceuticals And 3 Stocks To Watch Heading Into Tuesday
- What's Behind The Sharp 39% After-Hours Rally In Telomir Pharmaceuticals?
